EHA Unplugged

By: European Hematology Association
  • Summary

  • In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.
    © Copyright 2024 - European Hematology Association All rights reserved.
    Show More Show Less
activate_samplebutton_t1
Episodes
  • Gene Therapy for Hemophilia
    Sep 17 2024

    Join us for an insightful interview with Professor Frank Leebeek from Erasmus University in Rotterdam, The Netherlands, as he discusses together with our host, Dr. Isabel Olivera-Martinez, the potential of gene therapy to free hemophilia patients from the standard coagulation factor replacement therapy.

    Prof. Leebeek explains how gene therapy for hemophilia is carried out and differentiates the current possibilities for hemophilia A patients versus those with hemophilia B. He also highlights the advantages and challenges of this life-changing therapy, including its long-term effects, while addressing patient concerns related to safety and accessibility. Finally, he provides a glimpse into the future of gene therapy.

    Host: Isabel Olivera-Martinez, PhD, Medical Writer

    Guest: Prof Frank Leebeek

    Learn More

    If you liked this podcast and would like to explore related content, you can check out our EHA Gene Therapy Techniques Program on the EHA Campus.


    What did you think of this podcast? Share your opinions with us in this short feedback survey.

    Provide Feedback


    Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

    https://ehaedu.org/Campus


    Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

    Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

    Facebook: https://e-h-a.link/facebook

    LinkedIn: https://www.linkedin.com/company/eha/

    Email us: education@ehaweb.org

    Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

    Show More Show Less
    25 mins
  • AI-driven Morphology in Hematology
    Sep 6 2024

    In this podcast episode, we will explore the application of artificial intelligence to morphological diagnosis in hematology. Listening to our host, Dr Mahesh Prahladan (University of Suffolk, UK) you will learn how innovative machine learning and deep learning models have led to the development of AI systems that have been applied in various areas of hematology, including digital pathology.

    As these systems have shown promise in improving diagnostic accuracy and efficiency, they also have a potential for enlarging accessibility to precise diagnostics, through remote digital morphology, and have potential applications in the prognostic stratification of patients.

    According to Dr Prahladan, we are not ready to dispose of our microscopes yet, but automation may become a useful and time-saving tool in the hands of morphologists.

    Host: Dr Enrica Orsini

    Guest: Dr Mahesh Prahladan

    Learn More


    What did you think of this podcast? Share your opinions with us in this short feedback survey.

    Provide Feedback


    Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

    https://ehaedu.org/Campus


    Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

    Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

    Facebook: https://e-h-a.link/facebook

    LinkedIn: https://www.linkedin.com/company/eha/

    Email us: education@ehaweb.org

    Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

    Show More Show Less
    13 mins
  • Regulatory Landscape for CAR T-cell Therapy
    Aug 30 2024

    Join us for an interview with Professor Julio Delgado from the Hospital Clinic de Barcelona (Spain), the first academic centre to achieve the authorisation to treat patients with a CAR T therapy developed 100% by academia.

    Prof Delgado discusses the complexities of obtaining regulatory approval for CAR T-cell therapy, under the EU regulation for advanced therapy medicinal products (ATMPs).

    In this episode, Prof Delgado shares his own experience learning to navigate the EU regulatory expectations while working at the European Medicines Agency (EMA). He emphasizes the importance of scientists understanding these regulations and regulators understanding the specific position of academia in the approval pathway for ATMPs. Listen and take advantage of his valuable insights!

    Host: Isabel Olivera-Martinez, Medical Writer

    Guest: Prof Julio Delgado

    This episode is part of a series recorded at the joint EHA-EBMT 6th European CAR T-cell meeting in Valencia in February 2024, more podcasts will be available in the future. Stay tuned!

    Learn More


    Interested in more content related to CART? We've got you covered. Check out free CART program on EHA Campus.


    What did you think of this podcast? Share your opinions with us in this short feedback survey.

    Provide Feedback


    Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

    https://ehaedu.org/Campus


    Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

    Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

    Facebook: https://e-h-a.link/facebook

    LinkedIn: https://www.linkedin.com/company/eha/

    Email us: education@ehaweb.org

    Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

    Show More Show Less
    11 mins

What listeners say about EHA Unplugged

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.